Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Hypertension2364 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05772 | 33125745 | Hepatology | Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study. | 2021 | Details |
| A05790 | 33116709 | Diabetes Metab Syndr Obes | Relationship Between Gallstone Disease and Cardiometabolic Risk Factors in Elderly People with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05835 | 33102800 | Endocrinol Diabetes Metab | Perspectives on youth-onset nonalcoholic fatty liver disease. | 2020 | Details |
| A05860 | 33098023 | Dig Dis Sci | Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05927 | 33073044 | Transl Gastroenterol Hepatol | Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease. | 2020 | Details |
| A05938 | 33070425 | Int J Clin Pract | Relationship between coffee consumption, sleep duration and smoking status with elastographic parameters of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements. | 2020 | Details |
| A05942 | 33068638 | J Hepatol | Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis. | 2020 | Details |
| A05951 | 33065588 | Am J Gastroenterol | Risk Factor Profiles Can Distinguish Esophageal Adenocarcinoma From Barrett's Esophagus. | 2021 | Details |
| A05993 | 33047893 | Liver Transpl | Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium. | 2020 | Details |
| A05998 | 33045403 | Contemp Clin Trials | The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease. | 2020 | Details |
| A06011 | 33038432 | J Hepatol | Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis. | 2020 | Details |
| A06036 | 33032515 | Curr Med Imaging | Evaluation and Comparative Correlation of Abdominal Fat Related Parameters in Obese and Non-obese Groups Using Computed Tomography. | 2021 | Details |
| A06062 | 33024913 | Hepatol Commun | Differential Outcomes and Clinical Challenges of NAFLD With Extreme Obesity. | 2020 | Details |
| A06073 | 33016540 | Aliment Pharmacol Ther | Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06088 | 33011191 | Prog Lipid Res | The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation. | 2020 | Details |
| A06101 | 33007507 | Clin Gastroenterol Hepatol | The Clinical Spectrum and Diagnosis of Oxaliplatin Liver Injury in the Era of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06130 | 32994765 | Postepy Dermatol Alergol | Non-alcoholic fatty liver disease in patients with psoriasis: therapeutic implications. | 2019 | Details |
| A06159 | 32982495 | Hepat Med | Identifying High-Risk NASH Patients: What We Know so Far. | 2020 | Details |
| A06204 | 32970356 | Liver Int | Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure. | 2021 | Details |
| A06206 | 32967678 | Lipids Health Dis | Association between sitting time and non-alcoholic fatty live disease in South Korean population: a cross-sectional study. | 2020 | Details |
| A06216 | 32964202 | JHEP Rep | Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease. | 2020 | Details |
| A06217 | 32964201 | JHEP Rep | The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care. | 2020 | Details |
| A06254 | 32951749 | Complement Ther Med | Effects of green coffee bean extract on C-reactive protein levels: A systematic review and meta-analysis of randomized controlled trials. | 2020 | Details |
| A06260 | 32949785 | Ann Hepatol | Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease. | 2020 | Details |
| A06264 | 32947869 | Biomolecules | Inflammation in Obesity-Related Complications in Children: The Protective Effect of Diet and Its Potential Role as a Therapeutic Agent. | 2020 | Details |
| A06286 | 32941676 | J Clin Hypertens (Greenwich) | Abnormal cardiac and metabolic measures correlate significantly with lower performance and activity in overweight chronic liver disease. | 2020 | Details |
| A06303 | 32935743 | Arq Gastroenterol | DISTINCT PHENOTYPE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH LOW LEVELS OF FREE COPPER AND OF CERULOPLASMIN. | 2021 | Details |
| A06305 | 32934691 | Exp Ther Med | Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review). | 2020 | Details |
| A06306 | 32934047 | Clin Med (Lond) | Non-alcoholic fatty liver disease. | 2020 | Details |
| A06313 | 32932674 | Molecules | Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases. | 2020 | Details |
| A06325 | 32928581 | Clin Nutr | Adverse impact of egg consumption on fatty liver is partially explained by cardiometabolic risk factors: A population-based study. | 2020 | Details |
| A06331 | 32925501 | Eur J Gastroenterol Hepatol | Obstructive sleep apnea and severity of nonalcoholic fatty liver disease. | 2021 | Details |
| A06336 | 32924000 | Metabol Open | The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study. | 2020 | Details |
| A06360 | 32916379 | Nutrition | Pleiotropic ameliorative effects of ellagitannin geraniin against metabolic syndrome induced by high-fat diet in rats. | 2020 | Details |
| A06383 | 32903892 | Clin Exp Gastroenterol | Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver. | 2020 | Details |
| A06384 | 32902660 | Abdom Radiol (NY) | Performance of morphologic criteria for the diagnosis of cirrhosis in patients with non-alcoholic steatohepatitis compared to other etiologies of chronic liver disease: effect of level of training and experience. | 2020 | Details |
| A06411 | 32889666 | Rev Endocr Metab Disord | Hypothalamus-pituitary-adrenal Axis in Glucolipid metabolic disorders. | 2020 | Details |
| A06445 | 32879879 | Biomed Res Int | Endocan and Lumican in Relation to Cardiometabolic Risk in a Pediatric Overweight and Obese Cohort: A Cross-Sectional Study. | 2020 | Details |
| A06458 | 32874784 | PeerJ | Gender-specific associations between apolipoprotein A1 and arterial stiffness in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A06469 | 32868652 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study. | 2021 | Details |
| A06472 | 32866186 | PLoS One | Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome. | 2020 | Details |
| A06542 | 32832491 | Can J Gastroenterol Hepatol | Associations between Phase Angle Values Obtained by Bioelectrical Impedance Analysis and Nonalcoholic Fatty Liver Disease in an Overweight Population. | 2020 | Details |
| A06545 | 32831555 | J Family Community Med | Prevalence and risk factors for nonalcoholic fatty liver disease in obese children in rural Punjab, India. | 2020 | Details |
| A06556 | 32825885 | Indian J Tuberc | An unique case report: Unusual presentation of mediastinal lymph node tuberculosis in an adult. | 2020 | Details |
| A06572 | 32822391 | PLoS One | Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus. | 2020 | Details |
| A06580 | 32821336 | World J Hepatol | Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study. | 2020 | Details |
| A06582 | 32821068 | World J Gastroenterol | Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge. | 2020 | Details |
| A06631 | 32800834 | Life Sci | High fructose intake and the route towards cardiometabolic diseases. | 2020 | Details |
| A06653 | 32792584 | Sci Rep | Administration of small-molecule guanabenz acetate attenuates fatty liver and hyperglycemia associated with obesity. | 2020 | Details |
| A06676 | 32784205 | BMJ Open Gastroenterol | Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome. | 2020 | Details |
| A06678 | 32783310 | Int J Exp Pathol | A "Western Diet" promotes symptoms of hepatic steatosis in spontaneously hypertensive rats. | 2020 | Details |
| A06719 | 32770818 | Liver Int | Steatosis as main determinant of portal hypertension through a restriction of hepatic sinusoidal area in a dietary rat nash model. | 2020 | Details |
| A06731 | 32766474 | Hepatol Commun | Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities. | 2020 | Details |
| A06775 | 32751794 | Int J Mol Sci | Cold Press Pomegranate Seed Oil Attenuates Dietary-Obesity Induced Hepatic Steatosis and Fibrosis through Antioxidant and Mitochondrial Pathways in Obese Mice. | 2020 | Details |
| A06791 | 32744348 | J Food Biochem | Biochemical and histopathological assessment of liver in a rat model of metabolic syndrome induced by high-carbohydrate high-fat diet. | 2020 | Details |
| A06796 | 32742180 | Saudi J Biol Sci | The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A06803 | 32739036 | Am J Med Sci | Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian Setting. | 2020 | Details |
| A06815 | 32736956 | Nutr Metab Cardiovasc Dis | Elevated blood pressure, cardiometabolic risk and target organ damage in youth with overweight and obesity. | 2020 | Details |
| A06828 | 32732616 | Transplantation | Association of α 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation. | 2021 | Details |
| A06846 | 32725250 | Acta Derm Venereol | Hidradenitis Suppurativa is Associated with Non-alcoholic Fatty Liver Disease: A Cross-sectional Study. | 2020 | Details |
| A06857 | 32720262 | Obes Surg | Bariatric Surgery in the Setting of Liver Cirrhosis with Portal Hypertension: the Confection and Particularities of Roux-en-Y Gastric Bypass in a High-Risk Patient. | 2020 | Details |
| A06897 | 32706078 | Eur Rev Med Pharmacol Sci | Mediterranean diet and the prevention of non-alcoholic fatty liver disease: results from a case-control study. | 2020 | Details |
| A06915 | 32698692 | United European Gastroenterol J | Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease. | 2020 | Details |
| A06916 | 32698306 | Int J Environ Res Public Health | Association of Genetic and Environmental Factors with Non-Alcoholic Fatty Liver Disease in a Chinese Han Population. | 2020 | Details |
| A06925 | 32696080 | Clin Res Cardiol | NAFLD and cardiovascular diseases: a clinical review. | 2020 | Details |
| A06926 | 32695968 | JHEP Rep | New frontiers in liver resection for hepatocellular carcinoma. | 2020 | Details |
| A06961 | 32685936 | Explor Med | Nonalcoholic fatty liver disease and portal hypertension. | 2020 | Details |
| A06964 | 32684985 | Diabetol Metab Syndr | NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. | 2020 | Details |
| A06974 | 32681291 | Obes Surg | 1-Year Follow-up of Single Anastomosis Sleeve Ileal (SASI) Bypass in Morbid Obese Patients: Efficacy and Concerns. | 2020 | Details |
| A06981 | 32674529 | Clin Mol Hepatol | Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH. | 2020 | Details |
| A06997 | 32666779 | Pol Arch Intern Med | Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice. | 2020 | Details |
| A07007 | 32660189 | Zhonghua Gan Zang Bing Za Zhi | [Pancreatoduodenectomy and non-alcoholic fatty liver disease]. | 2020 | Details |
| A07041 | 32646847 | Clin Res Hepatol Gastroenterol | Concurrence of HBV infection and non-alcoholic fatty liver disease is associated with higher prevalence of chronic kidney disease. | 2020 | Details |
| A07048 | 32643194 | Prenat Diagn | Perinatal exposure to maternal obesity: Lasting cardiometabolic impact on offspring. | 2020 | Details |
| A07054 | 32639223 | Int J Vitam Nutr Res | Vitamin D levels are not associated with non-alcoholic fatty liver disease severity in a Brazilian population. | 2020 | Details |
| A07057 | 32638541 | J Cachexia Sarcopenia Muscle | Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey. | 2020 | Details |
| A07063 | 32636124 | Nutr Metab Cardiovasc Dis | Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD. | 2020 | Details |
| A07065 | 32634767 | J Trace Elem Med Biol | The sex-specific effects of blood lead, mercury, and cadmium levels on hepatic steatosis and fibrosis: Korean nationwide cross-sectional study. | 2020 | Details |
| A07084 | 32629123 | Clin Gastroenterol Hepatol | Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases. | 2020 | Details |
| A07098 | 32623006 | Clin Gastroenterol Hepatol | Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017-2018 National Health and Nutrition Examination Survey. | 2020 | Details |
| A07140 | 32605642 | BMC Endocr Disord | Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): A United Kingdom population-based cohort study using the health improvement network (THIN). | 2020 | Details |
| A07149 | 32599713 | Int J Mol Sci | Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age. | 2020 | Details |
| A07160 | 32595949 | F1000Res | Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis. | 2020 | Details |
| A07167 | 32594797 | Hypertension | Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories. | 2020 | Details |
| A07175 | 32592657 | Cell Metab | In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19. | 2020 | Details |
| A07184 | 32590801 | Medicine (Baltimore) | Coronary heart disease is associated with nonalcoholic fatty liver disease in patients without hypertension and diabetes. | 2020 | Details |
| A07188 | 32589264 | Eur J Clin Invest | COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics. | 2020 | Details |
| A07201 | 32585065 | Liver Int | Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multicentre United States experience. | 2020 | Details |
| A07233 | 32573017 | J Gastroenterol Hepatol | Global epidemiology of lean non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
| A07237 | 32572126 | Sci Rep | Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Nonobese Postmenopausal Women: A Cross-sectional Study. | 2020 | Details |
| A07240 | 32571100 | J Endourol | Nonalcoholic Fatty Liver Disease Is an Independent Risk Factor for Nephrolithiasis in Women: Findings from NHANES III. | 2020 | Details |
| A07247 | 32568734 | J Pediatr Endocrinol Metab | Definition and early diagnosis of metabolic syndrome in children. | 2020 | Details |
| A07264 | 32561910 | Am J Clin Pathol | Steatohepatitis-Like Changes in Hepatocellular Adenoma. | 2020 | Details |
| A07271 | 32559142 | Acta Clin Belg | Non-alcoholic fatty liver disease: correlation with hyperuricemia in a European Mediterranean population. | 2020 | Details |
| A07274 | 32558346 | Liver Int | Oxidative stress is associated with suspected non-alcoholic fatty liver disease and all-cause mortality in the general population. | 2020 | Details |
| A07276 | 32558189 | Liver Int | The risk of pregnancy-associated hypertension in women with nonalcoholic fatty liver disease. | 2020 | Details |
| A07279 | 32557741 | J Gastroenterol Hepatol | Clinical profile of non-alcoholic fatty liver disease in nonobese patients. | 2020 | Details |
| A07280 | 32557192 | Hepatol Int | Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A07281 | 32556752 | Surg Endosc | Long-term effects of one-anastomosis gastric bypass on liver histopathology in NAFLD cases: a prospective study. | 2020 | Details |
| A07307 | 32545650 | Nutrients | Serum Mac-2 Binding Protein Levels Associate with Metabolic Parameters and Predict Liver Fibrosis Progression in Subjects with Fatty Liver Disease: A 7-Year Longitudinal Study. | 2020 | Details |